arginine vasopressin has been researched along with Parkinson Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adhiyaman, V; Hobson, P; Meara, RJ | 1 |
| Arai, M | 3 |
| Bonafe, A; Heroum, C; Renard, D | 1 |
| Akerlund, M; Forsling, ML; Olsson, JE; Sundquist, J | 1 |
| Hofman, MA; Purba, JS; Swaab, DF | 1 |
| Hasegawa, Y; Hirayama, M; Ieda, T; Koike, Y; Niimi, Y; Sobue, G; Takahashi, A | 1 |
| Fairbairn, AF; Ferrier, IN; Jabeen, S; Leake, A; McKeith, IG; Perry, EK; Perry, RH | 1 |
| Akerlund, M; Forsling, ML; Lindvall, B; Olsson, JE | 1 |
1 trial(s) available for arginine vasopressin and Parkinson Disease
| Article | Year |
|---|---|
Ropinirole does not affect plasma arginine vasopressin levels in patients with advanced Parkinson's disease.
Topics: Aged; Arginine Vasopressin; Carbidopa; Catechols; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Humans; Inappropriate ADH Syndrome; Indoles; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease | 2012 |
9 other study(ies) available for arginine vasopressin and Parkinson Disease
| Article | Year |
|---|---|
Central and peripheral autonomic integrity in Parkinson's disease.
Topics: Aged; Arginine Vasopressin; Autonomic Nervous System; Blood Pressure; Case-Control Studies; Central Nervous System; Hand Strength; Heart Rate; Humans; Hypotension, Orthostatic; Middle Aged; Neural Pathways; Norepinephrine; Parkinson Disease; Posture; Valsalva Maneuver | 2008 |
Increased plasma arginine vasopressin levels in dopamine agonist-treated Parkinson's disease patients.
Topics: Aged; Arginine Vasopressin; Benzothiazoles; Carbidopa; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole | 2011 |
Levodopa in combination with carbidopa does not affect plasma arginine vasopressin levels in treatment-naïve older patients with Parkinson's disease: A before-after study.
Topics: Arginine Vasopressin; Carbidopa; Controlled Before-After Studies; Humans; Levodopa; Parkinson Disease | 2012 |
Transient lesion in the splenium of the corpus callosum after oral corticoid therapy.
Topics: Administration, Oral; Anti-Inflammatory Agents; Arginine Vasopressin; Confusion; Corpus Callosum; Demyelinating Diseases; Humans; Intervertebral Disc Displacement; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers, Myelinated; Parkinson Disease; Prednisone; Recovery of Function; Sodium; Water-Electrolyte Balance | 2007 |
Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases.
Topics: Adolescent; Adult; Aged; Arginine Vasopressin; Blood-Brain Barrier; Cerebrovascular Disorders; Dementia; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Nervous System Diseases; Parkinson Disease | 1983 |
Decreased number of oxytocin-immunoreactive neurons in the paraventricular nucleus of the hypothalamus in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Arginine Vasopressin; Female; Humans; Immunohistochemistry; Lewy Bodies; Male; Middle Aged; Neurons; Oxytocin; Paraventricular Hypothalamic Nucleus; Parkinson Disease; Substantia Innominata; Tyrosine 3-Monooxygenase | 1994 |
Clinical and physiological characteristics of autonomic failure with Parkinson's disease.
Topics: Aged; Arginine Vasopressin; Autonomic Nervous System Diseases; Female; Humans; Hypotension; Hypotension, Orthostatic; Male; Multiple System Atrophy; Norepinephrine; Parkinson Disease; Postprandial Period; Tilt-Table Test; Urinary Bladder; Urodynamics | 1999 |
Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine Vasopressin; Cerebral Cortex; Corticotropin-Releasing Hormone; Dementia; Female; Humans; Inclusion Bodies; Male; Neurofibrils; Neuropeptides; Neuropsychological Tests; Occipital Lobe; Parkinson Disease; Somatostatin; Temporal Lobe | 1991 |
Cerebrospinal fluid arginine vasopressin in Parkinson's disease, dementia, and other degenerative disorders.
Topics: Arginine Vasopressin; Blood-Brain Barrier; Brain Damage, Chronic; Cerebrovascular Disorders; Dementia; Female; Humans; Male; Middle Aged; Parkinson Disease | 1987 |